25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Shanghai Rendu Biotechnology Co. Ltd. A
Buy, Hold or Sell?

Let's analyze Shanghai Rendu Biotechnology Co. Ltd. A together

I guess you are interested in Shanghai Rendu Biotechnology Co. Ltd. A. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Shanghai Rendu Biotechnology Co. Ltd. A. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Shanghai Rendu Biotechnology Co. Ltd. A

I send you an email if I find something interesting about Shanghai Rendu Biotechnology Co. Ltd. A.

1. Quick Overview

1.1. Quick analysis of Shanghai Rendu Biotechnology Co. Ltd. A (30 sec.)










1.2. What can you expect buying and holding a share of Shanghai Rendu Biotechnology Co. Ltd. A? (30 sec.)

How much money do you get?

How much money do you get?
¥0.03
When do you have the money?
1 year
How often do you get paid?
40.0%

What is your share worth?

Current worth
¥23.47
Expected worth in 1 year
¥23.19
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
¥-0.08
Return On Investment
-0.2%

For what price can you sell your share?

Current Price per Share
¥43.00
Expected price per share
¥33.14 - ¥49.88
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Shanghai Rendu Biotechnology Co. Ltd. A (5 min.)




Live pricePrice per Share (EOD)
¥43.00

2.2. Growth of Shanghai Rendu Biotechnology Co. Ltd. A (5 min.)




Is Shanghai Rendu Biotechnology Co. Ltd. A growing?

Current yearPrevious yearGrowGrow %
How rich?$129.5m$132.2m-$842.4k-0.6%

How much money is Shanghai Rendu Biotechnology Co. Ltd. A making?

Current yearPrevious yearGrowGrow %
Making money$786k-$303k$1m138.6%
Net Profit Margin12.5%-5.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Shanghai Rendu Biotechnology Co. Ltd. A (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Shanghai Rendu Biotechnology Co. Ltd. A?

Welcome investor! Shanghai Rendu Biotechnology Co. Ltd. A's management wants to use your money to grow the business. In return you get a share of Shanghai Rendu Biotechnology Co. Ltd. A.

First you should know what it really means to hold a share of Shanghai Rendu Biotechnology Co. Ltd. A. And how you can make/lose money.

Speculation

The Price per Share of Shanghai Rendu Biotechnology Co. Ltd. A is ¥43.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Shanghai Rendu Biotechnology Co. Ltd. A.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Shanghai Rendu Biotechnology Co. Ltd. A, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥23.47. Based on the TTM, the Book Value Change Per Share is ¥-0.07 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.05 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Shanghai Rendu Biotechnology Co. Ltd. A.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.000.0%0.020.0%-0.010.0%0.010.0%0.010.0%
Usd Book Value Change Per Share-0.06-0.1%-0.010.0%-0.010.0%0.320.8%0.320.8%
Usd Dividend Per Share0.030.1%0.010.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.03-0.1%0.000.0%-0.010.0%0.330.8%0.330.8%
Usd Price Per Share3.63-5.23-6.50-6.31-6.31-
Price to Earnings Ratio419.36-197.90--261.66--11.16--11.16-
Price-to-Total Gains Ratio-109.44-269.17-63,689.07-25,614.80-25,614.80-
Price to Book Ratio1.12-1.59-1.96-1.91-1.91-
Price-to-Total Gains Ratio-109.44-269.17-63,689.07-25,614.80-25,614.80-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.934
Number of shares168
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.00
Usd Book Value Change Per Share-0.010.32
Usd Total Gains Per Share0.000.33
Gains per Quarter (168 shares)-0.4654.86
Gains per Year (168 shares)-1.86219.46
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
15-6-122218209
29-13-144435428
314-19-166653647
418-26-187870866
523-32-20910881085
628-39-221113061304
732-45-241315231523
837-52-261517411742
942-58-281719581961
1046-65-301821762180

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%7.03.00.070.0%7.03.00.070.0%7.03.00.070.0%7.03.00.070.0%
Book Value Change Per Share2.02.00.050.0%5.05.00.050.0%5.05.00.050.0%5.05.00.050.0%5.05.00.050.0%
Dividend per Share4.00.00.0100.0%4.00.06.040.0%4.00.06.040.0%4.00.06.040.0%4.00.06.040.0%
Total Gains per Share2.02.00.050.0%5.05.00.050.0%5.05.00.050.0%5.05.00.050.0%5.05.00.050.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Shanghai Rendu Biotechnology Co. Ltd. A compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.436-0.070-84%-0.103-76%2.347-119%2.347-119%
Book Value Per Share--23.46523.805-1%23.957-2%23.919-2%23.919-2%
Current Ratio--11.93112.469-4%11.365+5%11.532+3%11.532+3%
Debt To Asset Ratio--0.0810.085-5%0.107-24%0.100-19%0.100-19%
Debt To Equity Ratio--0.0880.093-6%0.120-27%0.111-20%0.111-20%
Dividend Per Share--0.1960.050+294%-+100%0.020+885%0.020+885%
Eps--0.0160.142-89%-0.055+450%0.090-83%0.090-83%
Free Cash Flow Per Share--0.0220.146-85%-0.213+1055%-0.052+334%-0.052+334%
Free Cash Flow To Equity Per Share--0.0220.146-85%-0.213+1055%-0.052+334%-0.052+334%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap1720000000.000+39%1051600000.0001516500000.000-31%1883100000.000-44%1829120000.000-43%1829120000.000-43%
Net Profit Margin--0.0150.125-88%-0.059+497%0.051-71%0.051-71%
Operating Margin----0%-0%-0%-0%
Operating Ratio--1.2531.157+8%1.418-12%1.268-1%1.268-1%
Pb Ratio1.832+39%1.1201.591-30%1.965-43%1.910-41%1.910-41%
Pe Ratio685.911+39%419.363197.902+112%-261.660+162%-11.165+103%-11.165+103%
Price Per Share43.000+39%26.29037.913-31%47.078-44%45.728-43%45.728-43%
Price To Free Cash Flow Ratio482.848+39%295.211205.532+44%-112.979+138%71.379+314%71.379+314%
Price To Total Gains Ratio-178.997-64%-109.438269.172-141%63689.068-100%25614.796-100%25614.796-100%
Quick Ratio--7.1143.370+111%6.307+13%4.050+76%4.050+76%
Return On Assets--0.0010.005-89%-0.002+438%0.003-82%0.003-82%
Return On Equity--0.0010.006-89%-0.002+446%0.004-82%0.004-82%
Total Gains Per Share---0.240-0.020-92%-0.103-57%2.366-110%2.366-110%
Usd Book Value--129529546.116131401874.449-1%132244371.674-2%132032059.059-2%132032059.059-2%
Usd Book Value Change Per Share---0.060-0.010-84%-0.014-76%0.324-119%0.324-119%
Usd Book Value Per Share--3.2383.285-1%3.306-2%3.301-2%3.301-2%
Usd Dividend Per Share--0.0270.007+294%-+100%0.003+885%0.003+885%
Usd Eps--0.0020.020-89%-0.008+450%0.012-83%0.012-83%
Usd Free Cash Flow--122895.874808418.985-85%-1173093.403+1055%-287814.914+334%-287814.914+334%
Usd Free Cash Flow Per Share--0.0030.020-85%-0.029+1055%-0.007+334%-0.007+334%
Usd Free Cash Flow To Equity Per Share--0.0030.020-85%-0.029+1055%-0.007+334%-0.007+334%
Usd Market Cap237360000.000+39%145120800.000209277000.000-31%259867800.000-44%252418560.000-43%252418560.000-43%
Usd Price Per Share5.934+39%3.6285.232-31%6.497-44%6.310-43%6.310-43%
Usd Profit--86512.662786004.565-89%-303009.187+450%495716.731-83%495716.731-83%
Usd Revenue--5777374.6155901655.739-2%7390474.754-22%7658187.739-25%7658187.739-25%
Usd Total Gains Per Share---0.033-0.003-92%-0.014-57%0.327-110%0.327-110%
 EOD+3 -5MRQTTM+7 -27YOY+20 -145Y+14 -2010Y+14 -20

3.3 Fundamental Score

Let's check the fundamental score of Shanghai Rendu Biotechnology Co. Ltd. A based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15685.911
Price to Book Ratio (EOD)Between0-11.832
Net Profit Margin (MRQ)Greater than00.015
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than17.114
Current Ratio (MRQ)Greater than111.931
Debt to Asset Ratio (MRQ)Less than10.081
Debt to Equity Ratio (MRQ)Less than10.088
Return on Equity (MRQ)Greater than0.150.001
Return on Assets (MRQ)Greater than0.050.001
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Shanghai Rendu Biotechnology Co. Ltd. A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.776
Ma 20Greater thanMa 5041.328
Ma 50Greater thanMa 10033.737
Ma 100Greater thanMa 20029.569
OpenGreater thanClose41.220
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Shanghai Rendu Biotechnology Co. Ltd. A

Shanghai Rendu Biotechnology Co., Ltd. engages in the development and promotion of RNA molecular diagnostic technology and products. The company offers products in the areas of reproductive health, respiratory diseases, enterovirus, food safety, and blood infectious diseases, as well as automatic nucleic acid detection and analysis system. The company was founded in 2007 and is based in Shanghai, China.

Fundamental data was last updated by Penke on 2024-11-10 10:01:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Shanghai Rendu Biotechnology Co. Ltd. A earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Shanghai Rendu Biotechnology Co. Ltd. A to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 1.5% means that ¥0.01 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Shanghai Rendu Biotechnology Co. Ltd. A:

  • The MRQ is 1.5%. The company is making a profit. +1
  • The TTM is 12.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ1.5%TTM12.5%-11.0%
TTM12.5%YOY-5.9%+18.4%
TTM12.5%5Y5.1%+7.4%
5Y5.1%10Y5.1%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5%-5.6%+7.1%
TTM12.5%-8.8%+21.3%
YOY-5.9%-0.8%-5.1%
5Y5.1%-1.9%+7.0%
10Y5.1%-0.5%+5.6%
4.3.1.2. Return on Assets

Shows how efficient Shanghai Rendu Biotechnology Co. Ltd. A is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Shanghai Rendu Biotechnology Co. Ltd. A to the Diagnostics & Research industry mean.
  • 0.1% Return on Assets means that Shanghai Rendu Biotechnology Co. Ltd. A generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Shanghai Rendu Biotechnology Co. Ltd. A:

  • The MRQ is 0.1%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.5%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.1%TTM0.5%-0.5%
TTM0.5%YOY-0.2%+0.7%
TTM0.5%5Y0.3%+0.2%
5Y0.3%10Y0.3%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1%-1.2%+1.3%
TTM0.5%-2.1%+2.6%
YOY-0.2%-0.9%+0.7%
5Y0.3%-0.1%+0.4%
10Y0.3%-0.5%+0.8%
4.3.1.3. Return on Equity

Shows how efficient Shanghai Rendu Biotechnology Co. Ltd. A is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Shanghai Rendu Biotechnology Co. Ltd. A to the Diagnostics & Research industry mean.
  • 0.1% Return on Equity means Shanghai Rendu Biotechnology Co. Ltd. A generated ¥0.00 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Shanghai Rendu Biotechnology Co. Ltd. A:

  • The MRQ is 0.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.6%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.1%TTM0.6%-0.5%
TTM0.6%YOY-0.2%+0.8%
TTM0.6%5Y0.4%+0.2%
5Y0.4%10Y0.4%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1%-0.5%+0.6%
TTM0.6%-1.7%+2.3%
YOY-0.2%0.3%-0.5%
5Y0.4%-0.9%+1.3%
10Y0.4%-0.9%+1.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Shanghai Rendu Biotechnology Co. Ltd. A.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Shanghai Rendu Biotechnology Co. Ltd. A is operating .

  • Measures how much profit Shanghai Rendu Biotechnology Co. Ltd. A makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Shanghai Rendu Biotechnology Co. Ltd. A to the Diagnostics & Research industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Shanghai Rendu Biotechnology Co. Ltd. A:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--9.7%+9.7%
TTM--12.8%+12.8%
YOY-3.3%-3.3%
5Y-0.5%-0.5%
10Y-3.1%-3.1%
4.3.2.2. Operating Ratio

Measures how efficient Shanghai Rendu Biotechnology Co. Ltd. A is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 1.25 means that the operating costs are ¥1.25 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Shanghai Rendu Biotechnology Co. Ltd. A:

  • The MRQ is 1.253. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.157. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.253TTM1.157+0.096
TTM1.157YOY1.418-0.261
TTM1.1575Y1.268-0.111
5Y1.26810Y1.2680.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2531.254-0.001
TTM1.1571.284-0.127
YOY1.4181.266+0.152
5Y1.2681.208+0.060
10Y1.2681.191+0.077
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Shanghai Rendu Biotechnology Co. Ltd. A.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Shanghai Rendu Biotechnology Co. Ltd. A is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 11.93 means the company has ¥11.93 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Shanghai Rendu Biotechnology Co. Ltd. A:

  • The MRQ is 11.931. The company is very able to pay all its short-term debts. +2
  • The TTM is 12.469. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ11.931TTM12.469-0.538
TTM12.469YOY11.365+1.104
TTM12.4695Y11.532+0.937
5Y11.53210Y11.5320.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ11.9312.028+9.903
TTM12.4692.113+10.356
YOY11.3652.555+8.810
5Y11.5322.668+8.864
10Y11.5323.229+8.303
4.4.3.2. Quick Ratio

Measures if Shanghai Rendu Biotechnology Co. Ltd. A is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Shanghai Rendu Biotechnology Co. Ltd. A to the Diagnostics & Research industry mean.
  • A Quick Ratio of 7.11 means the company can pay off ¥7.11 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Shanghai Rendu Biotechnology Co. Ltd. A:

  • The MRQ is 7.114. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.370. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.114TTM3.370+3.744
TTM3.370YOY6.307-2.936
TTM3.3705Y4.050-0.680
5Y4.05010Y4.0500.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ7.1141.228+5.886
TTM3.3701.241+2.129
YOY6.3071.803+4.504
5Y4.0502.100+1.950
10Y4.0502.435+1.615
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Shanghai Rendu Biotechnology Co. Ltd. A.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Shanghai Rendu Biotechnology Co. Ltd. A assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Shanghai Rendu Biotechnology Co. Ltd. A to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.08 means that Shanghai Rendu Biotechnology Co. Ltd. A assets are financed with 8.1% credit (debt) and the remaining percentage (100% - 8.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Shanghai Rendu Biotechnology Co. Ltd. A:

  • The MRQ is 0.081. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.085. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.081TTM0.085-0.004
TTM0.085YOY0.107-0.022
TTM0.0855Y0.100-0.014
5Y0.10010Y0.1000.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0810.437-0.356
TTM0.0850.440-0.355
YOY0.1070.359-0.252
5Y0.1000.428-0.328
10Y0.1000.450-0.350
4.5.4.2. Debt to Equity Ratio

Measures if Shanghai Rendu Biotechnology Co. Ltd. A is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Shanghai Rendu Biotechnology Co. Ltd. A to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 8.8% means that company has ¥0.09 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Shanghai Rendu Biotechnology Co. Ltd. A:

  • The MRQ is 0.088. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.093. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.088TTM0.093-0.005
TTM0.093YOY0.120-0.027
TTM0.0935Y0.111-0.018
5Y0.11110Y0.1110.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0880.640-0.552
TTM0.0930.686-0.593
YOY0.1200.502-0.382
5Y0.1110.666-0.555
10Y0.1110.712-0.601
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Shanghai Rendu Biotechnology Co. Ltd. A generates.

  • Above 15 is considered overpriced but always compare Shanghai Rendu Biotechnology Co. Ltd. A to the Diagnostics & Research industry mean.
  • A PE ratio of 419.36 means the investor is paying ¥419.36 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Shanghai Rendu Biotechnology Co. Ltd. A:

  • The EOD is 685.911. Based on the earnings, the company is expensive. -2
  • The MRQ is 419.363. Based on the earnings, the company is expensive. -2
  • The TTM is 197.902. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD685.911MRQ419.363+266.548
MRQ419.363TTM197.902+221.460
TTM197.902YOY-261.660+459.563
TTM197.9025Y-11.165+209.067
5Y-11.16510Y-11.1650.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD685.911-0.407+686.318
MRQ419.363-0.693+420.056
TTM197.902-0.881+198.783
YOY-261.660-0.145-261.515
5Y-11.1651.937-13.102
10Y-11.1653.729-14.894
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Shanghai Rendu Biotechnology Co. Ltd. A:

  • The EOD is 482.848. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 295.211. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 205.532. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD482.848MRQ295.211+187.637
MRQ295.211TTM205.532+89.678
TTM205.532YOY-112.979+318.511
TTM205.5325Y71.379+134.154
5Y71.37910Y71.3790.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD482.848-0.595+483.443
MRQ295.211-1.060+296.271
TTM205.532-1.123+206.655
YOY-112.979-2.356-110.623
5Y71.379-2.367+73.746
10Y71.379-2.248+73.627
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Shanghai Rendu Biotechnology Co. Ltd. A is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 1.12 means the investor is paying ¥1.12 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Shanghai Rendu Biotechnology Co. Ltd. A:

  • The EOD is 1.832. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.120. Based on the equity, the company is underpriced. +1
  • The TTM is 1.591. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.832MRQ1.120+0.712
MRQ1.120TTM1.591-0.470
TTM1.591YOY1.965-0.374
TTM1.5915Y1.910-0.319
5Y1.91010Y1.9100.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD1.8322.297-0.465
MRQ1.1202.330-1.210
TTM1.5912.320-0.729
YOY1.9652.384-0.419
5Y1.9103.753-1.843
10Y1.9104.539-2.629
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,021,502
Total Liabilities82,882
Total Stockholder Equity938,620
 As reported
Total Liabilities 82,882
Total Stockholder Equity+ 938,620
Total Assets = 1,021,502

Assets

Total Assets1,021,502
Total Current Assets869,413
Long-term Assets152,089
Total Current Assets
Cash And Cash Equivalents 242,029
Short-term Investments 446,032
Net Receivables 72,398
Inventory 25,186
Other Current Assets 79,603
Total Current Assets  (as reported)869,413
Total Current Assets  (calculated)865,248
+/- 4,165
Long-term Assets
Property Plant Equipment 89,492
Intangible Assets 524
Long-term Assets Other 41,409
Long-term Assets  (as reported)152,089
Long-term Assets  (calculated)131,425
+/- 20,664

Liabilities & Shareholders' Equity

Total Current Liabilities72,872
Long-term Liabilities10,010
Total Stockholder Equity938,620
Total Current Liabilities
Short Long Term Debt 2,911
Accounts payable 3,820
Other Current Liabilities 140
Total Current Liabilities  (as reported)72,872
Total Current Liabilities  (calculated)6,871
+/- 66,002
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt2,797
Long-term Liabilities Other 3
Long-term Liabilities  (as reported)10,010
Long-term Liabilities  (calculated)2,800
+/- 7,210
Total Stockholder Equity
Retained Earnings 132,956
Total Stockholder Equity (as reported)938,620
Total Stockholder Equity (calculated)132,956
+/- 805,664
Other
Capital Stock40,000
Common Stock Shares Outstanding 40,000
Net Invested Capital 941,531
Net Working Capital 796,540
Property Plant and Equipment Gross 89,492



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-31
> Total Assets 
1,083,745
1,087,586
1,086,542
1,088,722
1,066,374
1,053,269
1,047,716
1,054,716
1,040,825
1,021,502
1,021,5021,040,8251,054,7161,047,7161,053,2691,066,3741,088,7221,086,5421,087,5861,083,745
   > Total Current Assets 
982,346
986,166
975,116
972,582
951,717
936,007
934,008
899,142
887,219
869,413
869,413887,219899,142934,008936,007951,717972,582975,116986,166982,346
       Cash And Cash Equivalents 
874,755
846,196
724,292
298,933
273,236
288,901
681,826
609,567
589,909
242,029
242,029589,909609,567681,826288,901273,236298,933724,292846,196874,755
       Short-term Investments 
0
0
110,000
530,979
550,287
521,630
130,643
50,210
40,021
446,032
446,03240,02150,210130,643521,630550,287530,979110,00000
       Net Receivables 
77,695
98,829
100,722
104,863
88,432
86,287
81,431
76,806
69,604
72,398
72,39869,60476,80681,43186,28788,432104,863100,72298,82977,695
       Inventory 
20,053
26,478
28,180
28,291
31,509
31,148
31,174
28,595
27,025
25,186
25,18627,02528,59531,17431,14831,50928,29128,18026,47820,053
       Other Current Assets 
489
6,268
5,502
3,935
4,036
4,258
3,722
129,429
155,290
79,603
79,603155,290129,4293,7224,2584,0363,9355,5026,268489
   > Long-term Assets 
101,400
101,420
111,426
116,139
114,657
117,262
113,707
155,574
153,606
152,089
152,089153,606155,574113,707117,262114,657116,139111,426101,420101,400
       Property Plant Equipment 
0
0
0
0
97,108
95,908
92,467
92,718
90,842
89,492
89,49290,84292,71892,46795,90897,1080000
       Intangible Assets 
553
509
711
662
604
547
489
450
402
524
524402450489547604662711509553
       Long-term Assets Other 
1,883
1,104
316
1,205
1,890
792
550
41,150
41,212
41,409
41,40941,21241,1505507921,8901,2053161,1041,883
> Total Liabilities 
124,399
121,312
120,260
127,337
110,653
103,486
96,395
91,974
84,757
82,882
82,88284,75791,97496,395103,486110,653127,337120,260121,312124,399
   > Total Current Liabilities 
99,927
97,110
91,880
95,462
79,888
73,443
65,520
78,447
72,561
72,872
72,87272,56178,44765,52073,44379,88895,46291,88097,11099,927
       Short Long Term Debt 
1,593
1,754
1,914
2,601
2,178
1,994
684
2,925
2,499
2,911
2,9112,4992,9256841,9942,1782,6011,9141,7541,593
       Accounts payable 
16,721
20,367
9,981
11,380
3,635
5,822
5,581
4,094
3,905
3,820
3,8203,9054,0945,5815,8223,63511,3809,98120,36716,721
       Other Current Liabilities 
513
344
0
139
166
142
173
132
147
140
1401471321731421661390344513
   > Long-term Liabilities 
24,472
24,202
28,381
31,875
30,765
30,043
30,876
13,527
12,196
10,010
10,01012,19613,52730,87630,04330,76531,87528,38124,20224,472
       Capital Lease Obligations Min Short Term Debt
2,036
1,855
6,181
7,910
6,722
6,007
7,009
4,091
3,879
2,797
2,7973,8794,0917,0096,0076,7227,9106,1811,8552,036
       Long-term Liabilities Other 
236
147
0
46
42
26
5
12
0
3
301252642460147236
> Total Stockholder Equity
959,346
966,274
966,281
961,385
955,721
949,783
951,320
962,742
956,068
938,620
938,620956,068962,742951,320949,783955,721961,385966,281966,274959,346
   Common Stock0000000000
   Retained Earnings 
128,228
133,343
135,176
134,752
128,360
119,560
121,409
136,464
140,168
132,956
132,956140,168136,464121,409119,560128,360134,752135,176133,343128,228
   Capital Surplus 0000000000
   Treasury Stock0000000000
   Other Stockholders Equity 0000000000



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue164,412
Cost of Revenue-30,610
Gross Profit133,802133,802
 
Operating Income (+$)
Gross Profit133,802
Operating Expense-172,734
Operating Income-8,322-38,932
 
Operating Expense (+$)
Research Development41,136
Selling General Administrative97,659
Selling And Marketing Expenses0
Operating Expense172,734138,796
 
Net Interest Income (+$)
Interest Income8,725
Interest Expense-431
Other Finance Cost-35
Net Interest Income8,258
 
Pretax Income (+$)
Operating Income-8,322
Net Interest Income8,258
Other Non-Operating Income Expenses0
Income Before Tax (EBT)4,763-8,322
EBIT - interestExpense = -431
8,259
8,690
Interest Expense431
Earnings Before Interest and Taxes (EBIT)05,194
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax4,763
Tax Provision--3,497
Net Income From Continuing Ops8,2598,259
Net Income8,259
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-8,258
 

Technical Analysis of Shanghai Rendu Biotechnology Co. Ltd. A
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Shanghai Rendu Biotechnology Co. Ltd. A. The general trend of Shanghai Rendu Biotechnology Co. Ltd. A is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Shanghai Rendu Biotechnology Co. Ltd. A's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Shanghai Rendu Biotechnology Co. Ltd. A.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 46.78 < 48.80 < 49.88.

The bearish price targets are: 39.52 > 35.04 > 33.14.

Tweet this
Shanghai Rendu Biotechnology Co. Ltd. A Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Shanghai Rendu Biotechnology Co. Ltd. A. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shanghai Rendu Biotechnology Co. Ltd. A Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Shanghai Rendu Biotechnology Co. Ltd. A. The current macd is 2.20739993.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Shanghai Rendu Biotechnology Co. Ltd. A price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Shanghai Rendu Biotechnology Co. Ltd. A. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Shanghai Rendu Biotechnology Co. Ltd. A price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Shanghai Rendu Biotechnology Co. Ltd. A Daily Moving Average Convergence/Divergence (MACD) ChartShanghai Rendu Biotechnology Co. Ltd. A Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Shanghai Rendu Biotechnology Co. Ltd. A. The current adx is 43.97.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Shanghai Rendu Biotechnology Co. Ltd. A shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Shanghai Rendu Biotechnology Co. Ltd. A Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Shanghai Rendu Biotechnology Co. Ltd. A. The current sar is 49.07.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Shanghai Rendu Biotechnology Co. Ltd. A Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Shanghai Rendu Biotechnology Co. Ltd. A. The current rsi is 61.78. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Shanghai Rendu Biotechnology Co. Ltd. A Daily Relative Strength Index (RSI) ChartShanghai Rendu Biotechnology Co. Ltd. A Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Shanghai Rendu Biotechnology Co. Ltd. A. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Shanghai Rendu Biotechnology Co. Ltd. A price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Shanghai Rendu Biotechnology Co. Ltd. A Daily Stochastic Oscillator ChartShanghai Rendu Biotechnology Co. Ltd. A Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Shanghai Rendu Biotechnology Co. Ltd. A. The current cci is 22.37.

Shanghai Rendu Biotechnology Co. Ltd. A Daily Commodity Channel Index (CCI) ChartShanghai Rendu Biotechnology Co. Ltd. A Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Shanghai Rendu Biotechnology Co. Ltd. A. The current cmo is 22.31.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Shanghai Rendu Biotechnology Co. Ltd. A Daily Chande Momentum Oscillator (CMO) ChartShanghai Rendu Biotechnology Co. Ltd. A Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Shanghai Rendu Biotechnology Co. Ltd. A. The current willr is -65.17857143.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Shanghai Rendu Biotechnology Co. Ltd. A is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Shanghai Rendu Biotechnology Co. Ltd. A Daily Williams %R ChartShanghai Rendu Biotechnology Co. Ltd. A Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Shanghai Rendu Biotechnology Co. Ltd. A.

Shanghai Rendu Biotechnology Co. Ltd. A Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Shanghai Rendu Biotechnology Co. Ltd. A. The current atr is 2.51769932.

Shanghai Rendu Biotechnology Co. Ltd. A Daily Average True Range (ATR) ChartShanghai Rendu Biotechnology Co. Ltd. A Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Shanghai Rendu Biotechnology Co. Ltd. A. The current obv is 5,911,493.

Shanghai Rendu Biotechnology Co. Ltd. A Daily On-Balance Volume (OBV) ChartShanghai Rendu Biotechnology Co. Ltd. A Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Shanghai Rendu Biotechnology Co. Ltd. A. The current mfi is 62.11.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Shanghai Rendu Biotechnology Co. Ltd. A Daily Money Flow Index (MFI) ChartShanghai Rendu Biotechnology Co. Ltd. A Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Shanghai Rendu Biotechnology Co. Ltd. A.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-23BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-27BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-26STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Shanghai Rendu Biotechnology Co. Ltd. A Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Shanghai Rendu Biotechnology Co. Ltd. A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.776
Ma 20Greater thanMa 5041.328
Ma 50Greater thanMa 10033.737
Ma 100Greater thanMa 20029.569
OpenGreater thanClose41.220
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Shanghai Rendu Biotechnology Co. Ltd. A with someone you think should read this too:
  • Are you bullish or bearish on Shanghai Rendu Biotechnology Co. Ltd. A? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Shanghai Rendu Biotechnology Co. Ltd. A? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Shanghai Rendu Biotechnology Co. Ltd. A

I send you an email if I find something interesting about Shanghai Rendu Biotechnology Co. Ltd. A.


Comments

How you think about this?

Leave a comment

Stay informed about Shanghai Rendu Biotechnology Co. Ltd. A.

Receive notifications about Shanghai Rendu Biotechnology Co. Ltd. A in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.